Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Simultaneous Delivery of antim...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Simultaneous Delivery of antimiR-21 and Doxorubicin by Graphene Oxide for Reducing Toxicity in Cancer Therapy

Simultaneous Delivery of antimiR-21 and Doxorubicin by Graphene Oxide for Reducing Toxicity in Cancer Therapy

Bibliographic Details
Main Authors: Zhaoqi Yang, Dutao Yang, Kai Zeng, Dangran Li, Lan Qin, Yanfei Cai, Jian Jin
Format: Article
Language:English
Published: American Chemical Society 2020-06-01
Series:ACS Omega
Online Access:https://doi.org/10.1021/acsomega.0c01010
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1021/acsomega.0c01010

Similar Items

  • Systemic antimiR-337-3p delivery inhibits cerebral ischemia-mediated injury
    by: Xiaomin Wang, et al.
    Published: (2017-09-01)
  • Trimannose-coupled antimiR-21 for macrophage-targeted inhalation treatment of acute inflammatory lung damage
    by: Christina Beck, et al.
    Published: (2023-07-01)
  • AntimiR-155 Cyclic Peptide–PNA Conjugate: Synthesis, Cellular Uptake, and Biological Activity
    by: Terese Soudah, et al.
    Published: (2019-08-01)
  • Investigation of PLGA nanoparticles in conjunction with nuclear localization sequence for enhanced delivery of antimiR phosphorothioates in cancer cells in vitro
    by: Shipra Malik, et al.
    Published: (2019-04-01)
  • AntimiR targeting of microRNA-134 reduces seizures in a mouse model of Angelman syndrome
    by: Aoife Campbell, et al.
    Published: (2022-06-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs